Stocks To Watch For May 13, 2014
Goldman Sachs Group Inc (NYSE: GS) looks about ready to pop here. The stock needs break and close above its 200-day EMA at $160.73 to expect a strong rally at this point. Daily technical indicators are looking bullish. The MACD is above its signal line in negative territory with the signal line forming a rounding bottom pattern and the RSI is back above the 50 level. Lets see how this trades tomorrow.
JPMorgan Chase & Co. (NYSE: JPM) showed buying strength all day on Monday. Watching for $54.73 breakout. This momentum could push this stock much higher from here, so keep the stock on your radar for Tuesday's trading day, as there is good upside potential in this move.
ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) started the day negative but turned things around to close up nicely. Daily chart shows a possible reversal in the making.
VirnetX Holding Corporation (NYSEMKT:VHC) formed a bullish engulfing candle on the daily chart, what looks like the start of a strong bounce. I expect its up-move to continue and reach my first price target of 16.87 or 17 in the forthcoming trading sessions. VHC is certainly an interesting reversal candidate given the lengthy decline.
During the day I tweet many times to my readers. I encourage everybody to subscribe AC Investor Blog twitter and newsletter, so you can receive my trade ideas and stock news in real time.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.